360 High-Risk Vulnerability Immunization Tool V2.0 vs Fortra VM: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

Fortra VM: Risk-based vulnerability management platform for scanning and prioritization. built by Fortra. Core capabilities include Vulnerability scanning and identification, Risk-based vulnerability prioritization, Threat ranking based on real-world exploitation vectors..

Both serve the Vulnerability Assessment market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. Fortra VM differentiates with Vulnerability scanning and identification, Risk-based vulnerability prioritization, Threat ranking based on real-world exploitation vectors.

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). Fortra VM is developed by Fortra. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

360 High-Risk Vulnerability Immunization Tool V2.0 and Fortra VM serve similar Vulnerability Assessment use cases: both are Vulnerability Assessment tools. Review the feature comparison above to determine which fits your requirements.